[FG] Khanna Gremmelmaier Nina

Vock, I. et al. (2024) ‘Quantifying aminoglycoside resistance in extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales clinical isolates: a retrospective cohort study’, Swiss Medical Weekly, 154(10), p. 3904. Available at: https://doi.org/10.57187/s.3904.

Palianina, D. et al. (2024) ‘Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo’, Science Advances, 10(34). Available at: https://doi.org/10.1126/sciadv.ado2048.

Neofytos, D. and Khanna, N. (2024) ‘How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients’, Transplant Infectious Disease [Preprint]. Available at: https://doi.org/10.1111/tid.14332.

Portillo, V. et al. (2024) ‘Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae201.

Bausch, Severin et al. (2024) ‘Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study’, Antibiotics, 13(10), p. 928. Available at: https://doi.org/10.3390/antibiotics13100928.

De Greef, Julien et al. (2024) ‘Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Journal of Infection, 88. Available at: https://doi.org/10.1016/j.jinf.2024.106162.

Forrer, Pascal et al. (2024) ‘Unveiling signaling pathways inducing MHC class II expression in neutrophils’, Frontiers in Immunology, 15. Available at: https://doi.org/10.3389/fimmu.2024.1444558.

Hentzien, M. et al. (2024) ‘External validation of the Dat’AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older’, HIV Medicine, 25(1), pp. 72–82. Available at: https://doi.org/10.1111/hiv.13534.

Hofer, Kevin D. et al. (2024) ‘B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma’, British Journal of Haematology [Preprint]. Available at: https://doi.org/10.1111/bjh.19571.

Jantarug, Krittapas et al. (2024) ‘A Far-Red Fluorescent Probe to Visualize Gram-Positive Bacteria in Patient Samples’, ACS Infectious Diseases, 10, pp. 1545–1551. Available at: https://doi.org/10.1021/acsinfecdis.4c00060.

Kusejko, Katharina et al. (2024) ‘Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study’, BMC Infectious Diseases, 24. Available at: https://doi.org/10.1186/s12879-024-10026-7.

Maffei, Enea et al. (2024) ‘Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication’, Nature Communications, 15. Available at: https://doi.org/10.1038/s41467-023-44157-3.

Marais, Leonard C. et al. (2024) ‘Key aspects of soft tissue management in fracture-related infection: recommendations from an international expert group’, Archives of Orthopaedic and Trauma Surgery, 144, pp. 259–268. Available at: https://doi.org/10.1007/s00402-023-05073-9.

Müller-Durovic, Bojana et al. (2024) ‘A metabolic dependency of EBV can be targeted to hinder B cell transformation’, Science (New York, N.Y.), 385(6704), p. eadk4898. Available at: https://doi.org/10.1126/science.adk4898.

Ragozzino, Silvio et al. (2024) ‘Secondary attack rate following on-site isolation of patients with suspected COVID-19 in multiple-bed rooms’, Antimicrobial Resistance and Infection Control, 13. Available at: https://doi.org/10.1186/s13756-024-01430-4.

Rentsch, Katharina M. et al. (2024) ‘Enhancing Stability and Investigating Target Attainment of Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Insights from In Vitro and In Vivo Evaluations’, Antibiotics, 13(10), p. 970. Available at: https://doi.org/10.3390/antibiotics13100970.

Salmanton-García, Jon et al. (2024) ‘Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022’, eClinicalMedicine, 71. Available at: https://doi.org/10.1016/j.eclinm.2024.102553.

Søgaard, Kirstine K. et al. (2024) ‘Evaluation of the clinical relevance of the Biofire © FilmArray pneumonia panel among hospitalized patients’, Infection, 52, pp. 173–181. Available at: https://doi.org/10.1007/s15010-023-02080-1.

Sollier, Julie et al. (2024) ‘Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditions’, Nature Microbiology, 9(1), pp. 1–3. Available at: https://doi.org/10.1038/s41564-023-01566-w.

Zingg, Sandra et al. (2024) ‘Outbreak with OXA-23-producing Acinetobacter baumannii in a COVID-19 ICU cohort: unraveling routes of transmission’, Antimicrobial Resistance and Infection Control, 13. Available at: https://doi.org/10.1186/s13756-024-01485-3.

Criscuolo M et al. (2023) ‘SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report.’, Journal of investigational allergology & clinical immunology, 33(3), pp. 225–227. Available at: https://doi.org/10.18176/jiaci.0845.

Hoenigl M et al. (2023) ‘Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.’, The Lancet. Infectious diseases, 23(6), pp. 751–761. Available at: https://doi.org/10.1016/s1473-3099(22)00872-6.

Neofytos D et al. (2023) ‘Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update.’, Open forum infectious diseases, 10(6), p. ofad247. Available at: https://doi.org/10.1093/ofid/ofad247.

Ehrenzeller S et al. (2023) ‘A qualitative study on the perception of infection prevention and control measures among healthcare workers without patient contact during the SARS-CoV-2 pandemic.’, Antimicrobial resistance and infection control, 12(1), p. 43. Available at: https://doi.org/10.1186/s13756-023-01246-8.

Bettonte S et al. (2023) ‘Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(7), pp. 1225–1236. Available at: https://doi.org/10.1093/cid/ciac901.

Escrihuela-Vidal F et al. (2023) ‘Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort.’, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 29(4), pp. 498–505. Available at: https://doi.org/10.1016/j.cmi.2022.10.019.

Nguyen, A. et al. (2023) ‘Hot Topics 2022: die Sicht von jungen Infektiologinnen und Infektiologen’, Swiss Medical Forum ‒ Schweizerisches Medizin-Forum [Preprint]. Available at: https://doi.org/10.4414/smf.2023.09312.

Berton M et al. (2023) ‘Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals.’, Clinical pharmacokinetics, 62(2), pp. 277–295. Available at: https://doi.org/10.1007/s40262-022-01194-3.

Agnetti, Jessica et al. (2023) ‘Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy – a before-after study’, BMC Infectious Diseases, 23. Available at: https://doi.org/10.1186/s12879-023-08732-9.

Arendrup, M.C. et al. (2023) ‘European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study’, Journal of Infection, 87, pp. 428–437. Available at: https://doi.org/10.1016/j.jinf.2023.08.001.

Busca A et al. (2023) ‘Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.’, Frontiers in immunology, 14, p. 1125030. Available at: https://doi.org/10.3389/fimmu.2023.1125030.

Hosseini-Moghaddam, Seyed M. et al. (2023) ‘Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020’, American Journal of Transplantation, null. Available at: https://doi.org/10.1016/j.ajt.2023.11.003.

Labarile, Marco et al. (2023) ‘Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach’, Journal of Infectious Diseases, 227, pp. 554–564. Available at: https://doi.org/10.1093/infdis/jiac457.

Marchesi F et al. (2023) ‘COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).’, Haematologica, 108(1), pp. 22–33. Available at: https://doi.org/10.3324/haematol.2022.280847.

Ndege, R. et al. (2023) ‘Ultrasononography in managing extrapulmonary tuberculosis: a randomized, controlled, parallel, superiority, open-label trial’, Clin Infect Dis, 76(6), pp. 1013–1021. Available at: https://doi.org/10.1093/cid/ciac871.

Palianina, D. et al. (2023) ‘A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications’, Molecular Therapy - Methods and Clinical Development, 30, pp. 147–160. Available at: https://doi.org/10.1016/j.omtm.2023.06.007.

Ragozzino, Silvio et al. (2023) ‘Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study’, Bone Marrow Transplantation, null. Available at: https://doi.org/10.1038/s41409-023-02157-3.

Sava M et al. (2023) ‘Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates.’, 58(1). Available at: https://doi.org/10.1038/s41409-022-01851-y.

Schaeffer Thibault et al. (2023) ‘Long-Term Follow-Up after Mycobacterium Chimaera Infection Following Cardiac Surgery: Single-Center Experience’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12030948.

von Rotz, M. et al. (2023) ‘A systematic outbreak investigation of SARS-CoV-2 transmission clusters in a tertiary academic care center’, Antimicrob Resist Infect Control, 12(1), p. 38. Available at: https://doi.org/10.1186/s13756-023-01242-y.

Walti, C.S. et al. (2023) ‘New Treatment Options for Refractory/Resistant CMV Infection’, Transplant International, 36. Available at: https://doi.org/10.3389/ti.2023.11785.

Walti, Laura N. et al. (2023) ‘Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland’, JAMA Network Open, 6, p. E2310687. Available at: https://doi.org/10.1001/jamanetworkopen.2023.10687.

Chammartin F et al. (2022) ‘CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study.’, Journal of acquired immune deficiency syndromes (1999), 91(5), pp. 508–515. Available at: https://doi.org/10.1097/qai.0000000000003094.

Sgaard, K.K. et al. (2022) ‘Helicobacter cinaedi als seltener Auslöser bei einem immunkompetenten Patienten’, Swiss Medical Forum ‒ Schweizerisches Medizin-Forum [Preprint]. Available at: https://doi.org/10.4414/smf.2022.09011.

Castellanos-Rueda R et al. (2022) ‘speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing.’, Nature communications, 13(1), p. 6555. Available at: https://doi.org/10.1038/s41467-022-34141-8.

Gürtler N et al. (2022) ‘Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic.’, 129. Available at: https://doi.org/10.1016/j.jhin.2022.07.002.

Palianina, D. et al. (2022) A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell therapy applications. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.10.31.514542.

Blaskovich, Mark A. T. et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662). Available at: https://doi.org/10.1126/scitranslmed.abj2381.

Blaskovich MAT et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections.’, Science translational medicine, 14(662), p. eabj2381. Available at: https://doi.org/10.1126/scitranslmed.abj2381.

Berton M et al. (2022) ‘Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models.’, Clinical pharmacokinetics, 61(9), pp. 1251–1270. Available at: https://doi.org/10.1007/s40262-022-01132-3.

Darie, Andrei M et al. (2022) ‘Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.’, The Lancet. Respiratory medicine, 10(9), pp. 877–887. Available at: https://doi.org/10.1016/s2213-2600(22)00086-8.

Averbuch D et al. (2022) ‘Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75(1), pp. 88–97. Available at: https://doi.org/10.1093/cid/ciab866.

Walti CS et al. (2022) ‘Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients.’, Current opinion in infectious diseases, 35(4), pp. 302–311. Available at: https://doi.org/10.1097/qco.0000000000000838.

Thoueille P et al. (2022) ‘Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.’, Pharmaceutics, 14(8). Available at: https://doi.org/10.3390/pharmaceutics14081588.

Nguyen H et al. (2022) ‘Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.’, 74(12). Available at: https://doi.org/10.1093/cid/ciac242.

van den Bogaart L et al. (2022) ‘Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study.’, The Journal of infection, 85(1), pp. 1–7. Available at: https://doi.org/10.1016/j.jinf.2022.05.019.

Nguyen H et al. (2022) ‘Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74(8), pp. 1468–1475. Available at: https://doi.org/10.1093/cid/ciab628.

Busca A et al. (2022) ‘COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.’, Blood advances, 6(7), pp. 2427–2433. Available at: https://doi.org/10.1182/bloodadvances.2021005616.

Cardoso E et al. (2022) ‘Is sleep disordered breathing a risk factor for COVID-19 or vice versa?’, ERJ open research, 8(2). Available at: https://doi.org/10.1183/23120541.00034-2022.

Salina A et al. (2022) ‘Multiplex bacterial PCR in the bronchoalveolar lavage fluid of non-intubated patients with suspected pulmonary infection: a quasi-experimental study.’, ERJ open research, 8(2). Available at: https://doi.org/10.1183/23120541.00595-2021.

Stader F et al. (2022) ‘Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients.’, Clinical pharmacology and therapeutics, 111(3), pp. 579–584. Available at: https://doi.org/10.1002/cpt.2402.

Scherrer AU et al. (2022) ‘Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).’, International journal of epidemiology, 51(1), pp. 33–34j. Available at: https://doi.org/10.1093/ije/dyab141.

Ehrenzeller S et al. (2022) ‘A qualitative study on safety perception among healthcare workers of a tertiary academic care center during the SARS-CoV-2 pandemic.’, Antimicrobial resistance and infection control, 11(1), p. 30. Available at: https://doi.org/10.1186/s13756-022-01068-0.

Jakeman B et al. (2022) ‘Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study.’, The Journal of antimicrobial chemotherapy, 77(2), pp. 492–499. Available at: https://doi.org/10.1093/jac/dkab386.

Ragozzino S et al. (2022) ‘Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals.’, Open forum infectious diseases, 9(2), p. ofab638. Available at: https://doi.org/10.1093/ofid/ofab638.

Balakrishna, Suraj et al. (2022) ‘Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort Study’, Journal of Infectious Diseases, 225, pp. 1592–1600. Available at: https://doi.org/10.1093/infdis/jiab573.

Blaskovich Mark A.T. et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14. Available at: https://doi.org/10.1126/scitranslmed.abj238.

Bock, Lukas et al. (2022) ‘Air temperature and incidence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae’, Environmental Research, 215(Pt 2), p. 114146. Available at: https://doi.org/10.1016/j.envres.2022.114146.

Bruningk, Sarah C. et al. (2022) ‘Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area’, Virus Evolution, 8(1), p. veac002. Available at: https://doi.org/10.1093/ve/veac002.

Carere-Sigl, Anja et al. (2022) ‘FimH antagonists prevent biofilm formation on catheter surfaces’, Carbohydrate Chemistry, 45, pp. 519–536. Available at: https://doi.org/10.1039/9781839164538-00519.

Jahn K et al. (2022) ‘Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning.’, 59(1). Available at: https://doi.org/10.1183/13993003.01136-2021.

Kusejko, K. et al. (2022) ‘Similar but different: integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics’, J Acquir Immune Defic Syndr, 90(4), pp. e4–e12. Available at: https://doi.org/10.1097/qai.0000000000002949.

Kvarda, Peter et al. (2022) ‘Perioperative myocardial injury and mortality after revision surgery for orthopaedic device-related infection’, The Bone & Joint Journal, 104-B(6), pp. 696–702. Available at: https://doi.org/10.1302/0301-620x.104b6.bjj-2021-1486.r1.

Magnolini, R. et al. (2022) ‘Stigma-directed services (Stig2Health) to improve “linkage to care” for people living with HIV in rural Tanzania: study protocol for a nested pre-post implementation study within the Kilombero and Ulanga Antiretroviral Cohort’, AAS Open Res, 5, p. 14. Available at: https://doi.org/10.12688/aasopenres.13353.2.

Ndege, R. C. et al. (2022) ‘Failure to return pillbox is a predictor of being lost to follow-up among people living with HIV on antiretroviral therapy in rural Tanzania’, HIV Med, 23(6), pp. 661–672. Available at: https://doi.org/10.1111/hiv.13223.

Peter, Jelissa Katharina et al. (2022) ‘SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination’, Microorganisms, 10. Available at: https://doi.org/10.3390/microorganisms10050857.

Stöger, L. et al. (2022) ‘Persistent high burden and mortality associated with advanced HIV disease in rural Tanzania despite uptake of World Health Organization ‘test and treat’ guidelines’, Open Forum Infect Dis, 9(12), p. ofac611. Available at: https://doi.org/10.1093/ofid/ofac611.

Tepekule Burcu et al. (2022) ‘Impact of Latent Tuberculosis on Diabetes’, Journal of Infectious Diseases, 225, pp. 2229–2234. Available at: https://doi.org/10.1093/infdis/jiac054.

Weisser, M. et al. (2022) ‘The Chronic Diseases Clinic of Ifakara (CDCI)- establishing a model clinic for chronic care delivery in rural sub-Saharan Africa’, Diseases, 10(4), p. 72. Available at: https://doi.org/10.3390/diseases10040072.

Axfors C et al. (2021) ‘Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials.’, BMC infectious diseases, 21(1), p. 1170. Available at: https://doi.org/10.1186/s12879-021-06829-7.

Leuzinger K et al. (2021) ‘Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection.’, Journal of clinical microbiology, 59(12), p. e0138121. Available at: https://doi.org/10.1128/jcm.01381-21.

Stader F, Battegay M and Marzolini C (2021) ‘Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With Bictegravir.’, Clinical pharmacology and therapeutics, 110(5), pp. 1231–1239. Available at: https://doi.org/10.1002/cpt.2221.

Adam KM et al. (2021) ‘Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey.’, Open forum infectious diseases, 8(10), p. ofab471. Available at: https://doi.org/10.1093/ofid/ofab471.

Kowalska JD et al. (2021) ‘Prevalence and outcomes of pregnancies in women with HIV over a 20-year period.’, AIDS (London, England), 35(12), pp. 2025–2033. Available at: https://doi.org/10.1097/qad.0000000000002954.

Zweifel SA et al. (2021) ‘Long-Term Clinical and Multimodal Imaging Findings in Patients with Disseminated Mycobacterium Chimaera Infection.’, Journal of clinical medicine, 10(18). Available at: https://doi.org/10.3390/jcm10184178.

Hollinger A et al. (2021) ‘Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient-a case report and review of the literature.’, AIDS research and therapy, 18(1), p. 56. Available at: https://doi.org/10.1186/s12981-021-00382-8.

Di Roberto, R.B. et al. (2021) speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.08.23.457342.

Sava M et al. (2021) ‘Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study.’, Swiss medical weekly, 151, p. w20550. Available at: https://doi.org/10.4414/smw.2021.20550.

Thorball CW et al. (2021) ‘Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma.’, Haematologica, 106(8), pp. 2233–2241. Available at: https://doi.org/10.3324/haematol.2020.247023.

Sedlmayer F et al. (2021) ‘5-Fluorouracil blocks quorum-sensing of biofilm-embedded methicillin-resistant Staphylococcus aureus in mice.’, Nucleic acids research, 49(13), p. e73. Available at: https://doi.org/10.1093/nar/gkab251.

Diebold M et al. (2021) ‘Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study.’, Swiss medical weekly, 151, p. w20572. Available at: https://doi.org/10.4414/smw.2021.20572.

Kraljevic M et al. (2021) ‘Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients.’, Medical mycology, 59(7), pp. 701–711. Available at: https://doi.org/10.1093/mmy/myaa106.

Walti LN et al. (2021) ‘Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.’, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21(7), pp. 2532–2542. Available at: https://doi.org/10.1111/ajt.16423.

Nguyen H et al. (2021) ‘Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link.’, eLife, 10. Available at: https://doi.org/10.7554/elife.67388.

Hinić V et al. (2021) ‘Unexpected Mycoplasma hominis infection in two renal transplant recipients traced back to the same donor by whole-genome sequencing.’, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 40(5), pp. 1097–1102. Available at: https://doi.org/10.1007/s10096-020-04116-y.

Glampedakis E et al. (2021) ‘Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72(8), pp. 1379–1385. Available at: https://doi.org/10.1093/cid/ciaa230.

Glass TR et al. (2021) ‘The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72(8), pp. 1413–1421. Available at: https://doi.org/10.1093/cid/ciaa239.

Leuzinger K et al. (2021) ‘Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures.’, Journal of medical virology, 93(4), pp. 2374–2384. Available at: https://doi.org/10.1002/jmv.26731.

Stader F et al. (2021) ‘Physiologically-Based Pharmacokinetic Modeling Combined with Swiss HIV Cohort Study Data Supports No Dose Adjustment of Bictegravir in Elderly Individuals Living With HIV.’, Clinical pharmacology and therapeutics, 109(4), pp. 1025–1029. Available at: https://doi.org/10.1002/cpt.2178.

Janiaud P et al. (2021) ‘Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.’, JAMA, 325(12), pp. 1185–1195. Available at: https://doi.org/10.1001/jama.2021.2747.